{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:22:56Z","timestamp":1788200576186,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xops.2025.100875","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T20:46:53Z","timestamp":1751662013000},"page":"100875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suprachoroidal Injection of Topotecan for Retinoblastoma: A Preclinical Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-0320","authenticated-orcid":false,"given":"Arun D.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100875_bib1","series-title":"Clinical Ophthalmic Oncology: Retinoblastoma","first-page":"145","article-title":"Retinoblastoma: choosing treatment","author":"Singh","year":"2024"},{"key":"10.1016\/j.xops.2025.100875_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/neurintsurg-2019-014909","article-title":"Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis","volume":"11","author":"Ravindran","year":"2019","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.xops.2025.100875_bib3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death","volume":"93","author":"Kivel\u00e4","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/IJO.IJO_227_23","article-title":"Intraarterial chemotherapy for retinoblastoma in low and lower-middle-income countries \u2013 Can we break the barriers?","volume":"71","author":"Honavar","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib5","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.ophtha.2007.12.014","article-title":"A phase I\/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results","volume":"115","author":"Abramson","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100875_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146582","article-title":"Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for Group D retinoblastoma","volume":"11","author":"Abramson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100875_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08880018.2019.1677832","article-title":"Vincristine-induced peripheral neurotoxicity: a prospective cohort","volume":"37","author":"Nama","year":"2020","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.xops.2025.100875_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5306\/wjco.v11.i4.190","article-title":"Nephrotoxicity in cancer treatment: an overview","volume":"11","author":"Santos","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.xops.2025.100875_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102203","article-title":"Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: a systematic review and meta-analysis","volume":"79","author":"Dillard","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.xops.2025.100875_bib10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archopht.126.6.862","article-title":"The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?","volume":"126","author":"Rizzuti","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib11","author":"Jenkins"},{"key":"10.1016\/j.xops.2025.100875_bib12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/08820538.2014.959188","article-title":"Complications of intra-arterial chemotherapy for retinoblastoma","volume":"29","author":"Monroy","year":"2014","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/IAE.0b013e318203c101","article-title":"Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma","volume":"31","author":"Munier","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100875_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10147-004-0392-6","article-title":"The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma","volume":"9","author":"Yamane","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.xops.2025.100875_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156806","article-title":"Simultaneous bilateral ophthalmic artery chemosurgery for bilateral retinoblastoma (tandem therapy)","volume":"11","author":"Abramson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100875_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib17","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/IAE.0000000000000253","article-title":"Ocular pharmacology of topotecan and its activity in retinoblastoma","volume":"34","author":"Schaiquevich","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100875_bib18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bjophthalmol-2020-318529","article-title":"Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study","volume":"106","author":"Bogan","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104423","article-title":"Safety of intravitreal chemotherapy in the management of retinoblastoma: a systematic review of the literature","volume":"200","author":"Lavasidis","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.xops.2025.100875_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2024.12.012","article-title":"The role of intravitreal chemotherapy as an adjunctive treatment for retinoblastoma: a systematic review and single-arm meta-analysis","volume":"273","author":"Bravo-Gonzalez","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0000000000004283","article-title":"High-dose intravitreal topotecan for recurrent retinoblastoma, subretinal seeds, and vitreous seeds","volume":"45","author":"Shields","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100875_bib22","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2025.100875_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048188","article-title":"Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry","volume":"7","author":"Tyagi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100875_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/OPTH.S89784","article-title":"The suprachoroidal space: from potential space to a space with potential","volume":"10","author":"Moisseiev","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/tvst.5.6.14","article-title":"Suprachoroidal corticosteroid administration: a novel route for local treatment of noninfectious uveitis","volume":"5","author":"Goldstein","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2025.100875_bib27","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ophtha.2024.02.019","article-title":"Treatment of noninfectious uveitic macular edema with periocular and intraocular corticosteroid therapies: a report by the American Academy of Ophthalmology","volume":"131","author":"Smith","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100875_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.exer.2016.03.008","article-title":"Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries","volume":"145","author":"Chiang","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100875_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18240\/ijo.2022.01.03","article-title":"Characterization and validation of a chronic retinal neovascularization rabbit model by evaluating the efficacy of anti-angiogenic and anti-inflammatory drugs","volume":"15","author":"Kumar","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jop.2021.0090","article-title":"Suprachoroidal injection of triamcinolone acetonide suspension: ocular pharmacokinetics and distribution in rabbits demonstrates high and durable levels in the chorioretina","volume":"38","author":"Muya","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.xops.2025.100875_bib31","series-title":"Advances in Modern Toxicology: Dermatoxicology","first-page":"579","article-title":"Eye irritation","author":"McDonald","year":"1977"},{"key":"10.1016\/j.xops.2025.100875_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10633-004-3924-5","article-title":"Standardized full-field electroretinography in rabbits","volume":"109","author":"Gj\u00f6rloff","year":"2004","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108439","article-title":"Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: efficacy, toxicity and stability in rabbits models and patients","volume":"204","author":"Bogan","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100875_bib35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1167\/iovs.18-25346","article-title":"Rabbit model of intra-arterial chemotherapy toxicity demonstrates retinopathy and vasculopathy related to drug and dose, not procedure or approach","volume":"60","author":"Daniels","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2021.101358","article-title":"Complete preclinical platform for intravitreal chemotherapy drug discovery for retinoblastoma: assessment of pharmacokinetics, toxicity and efficacy using a rabbit model","volume":"8","author":"Daniels","year":"2021","journal-title":"MethodsX"},{"key":"10.1016\/j.xops.2025.100875_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.10.11.10","article-title":"Efficacy, toxicity, and pharmacokinetics of intra-arterial chemotherapy versus intravenous chemotherapy for retinoblastoma in animal models and patients","volume":"10","author":"Daniels","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2025.100875_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.30802\/AALAS-CM-18-000146","article-title":"Severe periocular edema after intraarterial carboplatin chemotherapy for retinoblastoma in a rabbit (Oryctolagus cuniculus) model","volume":"70","author":"Oatess","year":"2020","journal-title":"Comp Med"},{"key":"10.1016\/j.xops.2025.100875_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.62.14.8","article-title":"Intravitreal HDAC inhibitor belinostat effectively eradicates vitreous seeds without retinal toxicity in vivo in a rabbit retinoblastoma model","volume":"62","author":"Kaczmarek","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib40","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1167\/iovs.17-22302","article-title":"Pharmacokinetics, tissue localization, toxicity, and treatment efficacy in the first small animal (rabbit) model of intra-arterial chemotherapy for retinoblastoma","volume":"59","author":"Daniels","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0378-4347(96)00426-4","article-title":"Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs","volume":"691","author":"Warner","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.xops.2025.100875_bib42","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1167\/iovs.06-1152","article-title":"Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy","volume":"48","author":"Carcaboso","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib43","first-page":"1281","article-title":"Quantitative measurements of retinal edema by specific gravity determinations","volume":"28","author":"Stef\u00e1nsson","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib45","first-page":"33","article-title":"A short introduction to pharmacokinetics","volume":"6","author":"Urso","year":"2002","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.xops.2025.100875_bib46","author":"Rdocumentation"},{"key":"10.1016\/j.xops.2025.100875_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/01926233211047562","article-title":"Scientific and regulatory policy committee points to consider: fixation, trimming, and sectioning of nonrodent eyes and ocular tissues for examination in ocular and general toxicity studies","volume":"50","author":"Booler","year":"2022","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.xops.2025.100875_bib48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0192623318803854","article-title":"Historical data: histopathology lesions observed in the eyes of control rabbits in topical ocular administration and contact lens studies","volume":"46","author":"Langevin","year":"2018","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.xops.2025.100875_bib49","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1136\/bjophthalmol-2015-306633","article-title":"Properties and clinical utility of topotecan fluorescence: uses for retinoblastoma","volume":"99","author":"Francis","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28502","article-title":"A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: a Children\u2019s Oncology Group study (ARET 0231)","volume":"67","author":"Jubran","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.xops.2025.100875_bib51","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3928\/01913913-20230110-01","article-title":"Intravitreal topotecan 90 \u03bcg for recurrent solid retinoblastoma tumors Is effective and not toxic","volume":"60","author":"Abramson","year":"2023","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.xops.2025.100875_bib52","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/bjophthalmol-2021-319118","article-title":"Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy","volume":"106","author":"Zhou","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/archophthalmol.2011.5","article-title":"Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience","volume":"129","author":"Gobin","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamaophthalmol.2013.7288","article-title":"Characterization of the choroid-scleral junction and suprachoroidal layer in healthy individuals on enhanced-depth imaging optical coherence tomography","volume":"132","author":"Yiu","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000265503","article-title":"Suprachoroidal injection of sodium hyaluronate as an \u201cinternal\u201d buckling procedure","volume":"19","author":"Mittl","year":"1987","journal-title":"Ophthal Res"},{"key":"10.1016\/j.xops.2025.100875_bib57","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1167\/iovs.11-7525","article-title":"Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes","volume":"52","author":"Seiler","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib58","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/IAE.0000000000004087","article-title":"Suprachoroidal space injection technique: expert panel guidance","volume":"44","author":"Wykoff","year":"2024","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100875_bib59","first-page":"1209","article-title":"Safety of suprachoroidal injection procedure utilizing a microinjector across three retinal disorders","volume":"62","author":"Sharma","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1076\/opge.25.1.37.28996","article-title":"Activity of topotecan in retinoblastoma","volume":"25","author":"Chantada","year":"2004","journal-title":"Ophthal Genet"},{"key":"10.1016\/j.xops.2025.100875_bib61","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1002\/cncr.27563","article-title":"Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity","volume":"118","author":"Qaddoumi","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.xops.2025.100875_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/IAE.0b013e31821e9f8a","article-title":"Pharmacokinetic analysis of topotecan after superselective ophthalmic artery infusion and periocular administration in a porcine model","volume":"32","author":"Schaiquevich","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.100875_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151343","article-title":"Topotecan delivery to the optic nerve after ophthalmic artery chemosurgery","volume":"11","author":"Taich","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100875_bib64","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1167\/iovs.09-4050","article-title":"Episcleral implants for topotecan delivery to the posterior segment of the eye","volume":"51","author":"Carcaboso","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1600-0420.1997.tb00245.x","article-title":"Corrosion casts of the suprachoroidal space and uveoscleral drainage routes in the human eye","volume":"75","author":"Krohn","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.xops.2025.100875_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084247","article-title":"Electroretinogram monitoring of dose-dependent toxicity after ophthalmic artery chemosurgery in retinoblastoma eyes: six year review","volume":"9","author":"Francis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100875_bib67","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.jaapos.2020.12.006","article-title":"Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex","volume":"25","author":"Shields","year":"2021","journal-title":"J AAPOS"},{"key":"10.1016\/j.xops.2025.100875_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109026","article-title":"Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: implications for retinoblastoma treatment","volume":"218","author":"Del Sole","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100875_bib70","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ophtha.2024.04.022","article-title":"Intravitreal topotecan for vitreous seeds in retinoblastoma: a long-term review of 91 eyes","volume":"131","author":"Sen","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100875_bib71","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2017.4603","article-title":"Intracameral topotecan hydrochloride for anterior chamber seeding of retinoblastoma","volume":"135","author":"Paez-Escamilla","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bjo-2022-322492","article-title":"Ten-year experience with intracameral chemotherapy for aqueous seeding in retinoblastoma: long-term efficacy, safety and toxicity","volume":"108","author":"Stathopoulos","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.2016.69.2996","article-title":"Ocular salvage and vision preservation using a topotecan-based regimen for advanced intraocular retinoblastoma","volume":"35","author":"Brennan","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.xops.2025.100875_bib74","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/bjophthalmol-2012-301925","article-title":"Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results","volume":"96","author":"Marr","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100875_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072441","article-title":"Carboplatin +\/\u2212 topotecan ophthalmic artery chemosurgery for intraocular retinoblastoma","volume":"8","author":"Francis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xops.2025.100875_bib76","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.08-2737","article-title":"A phase I study of periocular topotecan in children with intraocular retinoblastoma","volume":"50","author":"Chantada","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100875_bib78","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1158\/1078-0432.CCR-05-0849","article-title":"Topotecan combination chemotherapy in two new rodent models of retinoblastoma","volume":"11","author":"Laurie","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.xops.2025.100875_bib79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exer.2017.07.001","article-title":"Hypoxia inhibits growth, proliferation, and increases response to chemotherapy in retinoblastoma cells","volume":"162","author":"Yang","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.xops.2025.100875_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102893","article-title":"The role of lactate metabolism in retinoblastoma tumorigenesis and ferroptosis resistance","volume":"95","author":"Zhang","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.xops.2025.100875_bib81","article-title":"Rabbit model of retinoblastoma","volume":"2011","author":"Kang","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.xops.2025.100875_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/srep33796","article-title":"Anterior eye tissue morphology: scleral and conjunctival thickness in children and young adults","volume":"6","author":"Read","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2025.100875_bib83","first-page":"320","article-title":"Distribution of aqueous solutions injected suprachoroidally (SC) in rabbits","volume":"61","author":"Nork","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525001733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525001733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T21:13:22Z","timestamp":1772054002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525001733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666914525001733"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100875","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suprachoroidal Injection of Topotecan for Retinoblastoma: A Preclinical Study","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100875"}}